TB-500 Dogs Horses Veterinary Applications: Research Comparison
Equine tendon injury Promotes cell migration into lesion, increases angiogenesis, reduces inflammatory cytokine persistence 10mg SC twice weekly × 4 weeks, then 10mg weekly × 8–12 weeks Moderate. Controlled studies show faster wound closure and vascularisation
This comparison does not assign a generated winner or score.
- Equine tendon injury
- Promotes cell migration into lesion, increases angiogenesis, reduces inflammatory cytokine persistence
- 10mg SC twice weekly × 4 weeks, then 10mg weekly × 8–12 weeks
- Moderate. Controlled studies show faster wound closure and vascularisation, but tensile strength improvement is inconsistent
- Most promising application. Ultrasound follow-up essential to confirm structural healing matches clinical improvement
- Canine surgical wound healing
- Accelerates keratinocyte migration, increases collagen deposition, reduces hypertrophic scar formation
- 2.5mg SC twice weekly × 4 weeks post-surgery
- Moderate. Small studies (n=20–40) show 30–40% faster epithelialisation vs controls
- Useful adjunct in high-risk surgical cases (e.g., large skin grafts, contaminated wounds). Not necessary for routine surgeries
- Equine joint inflammation (osteoarthritis)
- Modulates synovial cytokine environment, may reduce cartilage degradation markers
- 10mg IM weekly × 12 weeks, often combined with hyaluronic acid or corticosteroids
- Low. Anecdotal reports common, but controlled trials show minimal effect on lameness scores or radiographic progression
- Weak evidence. Hyaluronic acid alone produces similar outcomes at lower cost
- Canine cruciate ligament repair recovery
- Enhances ligament-bone interface healing, reduces post-surgical adhesion formation
- 2.5mg SC twice weekly × 6 weeks post-TPLO or TTA surgery
- Low-moderate. Retrospective case series suggest faster return to function, but no blinded RCTs exist
- Plausible mechanism, but current evidence doesn't justify routine use. Consider in competitive/working dogs where faster recovery has significant value
- Equine corneal ulcer healing
- Promotes corneal epithelial migration, increases tear film stability
- 5mg subconjunctival injection weekly × 3 weeks
- Low. Case reports only, no comparative trials
- Mechanistically sound, but subconjunctival injection carries risk. Standard topical therapy (autologous serum, atropine) remains first-line